X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (261) 261
Patent (49) 49
Book Chapter (26) 26
Publication (14) 14
Web Resource (8) 8
Book / eBook (5) 5
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
surgery (170) 170
female (153) 153
humans (152) 152
oncology (103) 103
index medicus (97) 97
breast cancer (82) 82
middle aged (80) 80
breast neoplasms - pathology (74) 74
aged (70) 70
adult (62) 62
breast neoplasms - surgery (62) 62
cancer (62) 62
medicine & public health (55) 55
surgical oncology (50) 50
diagnosis (42) 42
neoplasm staging (35) 35
animals (34) 34
human necessities (34) 34
hygiene (34) 34
medical or veterinary science (34) 34
biopsy (33) 33
aged, 80 and over (32) 32
breast (31) 31
rats (31) 31
retrospective studies (28) 28
male (27) 27
prognosis (26) 26
carcinoma (24) 24
care and treatment (24) 24
mastectomy (24) 24
lumpectomy (23) 23
prospective studies (22) 22
breast neoplasms - diagnostic imaging (21) 21
breast-cancer (20) 20
chemotherapy (20) 20
treatment outcome (19) 19
axilla (18) 18
follow-up studies (18) 18
health aspects (18) 18
identification (18) 18
lymph nodes - pathology (18) 18
metabolism (18) 18
preparations for medical, dental, or toilet purposes (18) 18
breast neoplasms - therapy (17) 17
lymphatic metastasis (17) 17
mastectomy, segmental (17) 17
carcinoma, ductal, breast - pathology (16) 16
glutamine (16) 16
glutathione (16) 16
investigating or analysing materials by determining theirchemical or physical properties (16) 16
measuring (16) 16
nutrition & dietetics (16) 16
physics (16) 16
testing (16) 16
dissection (15) 15
glutamine - pharmacology (15) 15
lymphadenectomy (15) 15
methods (15) 15
sentinel lymph node biopsy - methods (15) 15
therapy (15) 15
lesions (14) 14
sensitivity and specificity (14) 14
sentinel lymph node biopsy (14) 14
abridged index medicus (13) 13
breast neoplasms (13) 13
breast neoplasms - diagnosis (13) 13
chemistry (13) 13
glutamine - administration & dosage (13) 13
metallurgy (13) 13
radiation (13) 13
radionuclide imaging (13) 13
axillary dissection (12) 12
biopsy, needle (12) 12
breast neoplasms - drug therapy (12) 12
expression (12) 12
glutathione - metabolism (12) 12
lymphedema (12) 12
radiation-therapy (12) 12
rats, inbred f344 (12) 12
young adult (12) 12
administration, oral (11) 11
analysis (11) 11
combined modality therapy (11) 11
local recurrence (11) 11
magnetic resonance imaging (11) 11
mammography (11) 11
neoadjuvant chemotherapy (11) 11
research (11) 11
risk factors (11) 11
survival (11) 11
accuracy (10) 10
carcinoma, lobular - pathology (10) 10
doxorubicin (10) 10
glutamine - blood (10) 10
lymph nodes - diagnostic imaging (10) 10
prevention (10) 10
radiopharmaceuticals (10) 10
radiotherapy (10) 10
rats, sprague-dawley (10) 10
ultrasonography, mammary (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2001, Seminars in surgical oncology, Volume 20, no. 3., 173-250
Book
Annals of Surgical Oncology, ISSN 1068-9265, 8/2016, Volume 23, Issue 8, pp. 2375 - 2376
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, pp. e0160224 - e0160224
Cardiotoxicity of doxorubicin (DOX) remains an important health concern. DOX cardiotoxicity is cumulative-dose-dependent and begins with the first dose of... 
RHEUMATOID-ARTHRITIS | CHRONIC HEART-FAILURE | ANTHRACYCLINE CARDIOTOXICITY | SYSTEMIC-LUPUS-ERYTHEMATOSUS | NEUTROPHIL EXTRACELLULAR TRAPS | LOW-DENSITY GRANULOCYTES | MULTIDISCIPLINARY SCIENCES | INDUCED CARDIOMYOPATHY | PROGNOSTIC VALUE | EXPRESSION | CHEMOTHERAPY | Doxorubicin - therapeutic use | Leukocytes, Mononuclear - metabolism | Antibiotics, Antineoplastic - toxicity | Leukocytes, Mononuclear - drug effects | Humans | Middle Aged | Ventricular Function, Left - drug effects | Transcriptome | Biomarkers - blood | Breast Neoplasms - drug therapy | Doxorubicin - toxicity | Young Adult | Antibiotics, Antineoplastic - therapeutic use | Breast Neoplasms - pathology | Myocardium - metabolism | Adolescent | Heart - drug effects | Adult | Female | Leukocytes, Mononuclear - cytology | Doxorubicin - adverse effects | Complications and side effects | Breast cancer | Cardiovascular research | Drug therapy | Biological markers | Doxorubicin | Identification and classification | Health aspects | Heart | Laboratories | Toxicity | Oncology | Inflammatory response | Arthritis | Proteins | Granulocytes | Surgery | Peripheral blood | Heart diseases | Heart failure | Lupus | Research & development--R&D | Blood cells | Neutrophils | Leukocytes (neutrophilic) | Inflammation | Functional analysis | Gene expression | Patients | Asthma | Studies | Chemotherapy | Biomarkers | Breast | Kidney diseases | Cancer | Apoptosis | Index Medicus | Research & development | R&D
Journal Article
ANNALS OF SURGICAL ONCOLOGY, ISSN 1068-9265, 08/2016, Volume 23, Issue 8, pp. 2375 - 2376
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1245/s10434-016-5281-5 
SURGERY | ABLATION | ONCOLOGY | BREAST | Cryosurgery | Breast Neoplasms | Humans | Freezing
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e48398
Aims: Doxorubicin (DOX), a widely used anticancer agent, can cause an unpredictable cardiac toxicity which remains a major limitation in cancer chemotherapy.... 
MYOCARDIAL DAMAGE | CHEMOTHERAPEUTIC-AGENTS | PROTEASOME PATHWAY | UBIQUITIN | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | IN-VIVO | GENE-EXPRESSION | ANTHRACYCLINE-INDUCED CARDIOTOXICITY | B SIGNALING PATHWAY | NF-KAPPA-B | Leukocytes, Mononuclear - metabolism | Reproducibility of Results | Signal Transduction | Molecular Sequence Annotation | Rats | Gene Expression Profiling | Thrombocytopenia - chemically induced | Antineoplastic Agents - administration & dosage | Doxorubicin - pharmacokinetics | Doxorubicin - toxicity | Antineoplastic Agents - toxicity | Gene Expression Regulation - drug effects | Animals | Myocardium - metabolism | Biomarkers | Heart - drug effects | Female | Antineoplastic Agents - pharmacokinetics | Heart Diseases - chemically induced | Heart Diseases - genetics | Doxorubicin - administration & dosage | Lymphopenia - chemically induced | Anthracyclines | Chemotherapy | Genes | Genomics | Biological markers | Gene expression | Health aspects | Cancer | Heart | Oxidative stress | Profiling | Toxicity | Cardiomyopathy | Leukocytes (mononuclear) | Oncology | Genomes | Damage prevention | Cancer therapies | Doxorubicin | Blood | Anticancer properties | Proteins | Pathways | Rodents | Peripheral blood mononuclear cells | Bioindicators | Heart diseases | Hematology | Blood cells | Patients | DNA microarrays | Data sets | Cardiovascular diseases | Laboratory animals
Journal Article
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, ISSN 0022-3565, 11/2019, Volume 371, Issue 2, pp. 278 - 289
Doxorubicin is a risk factor for secondary lymphedema in cancer patients exposed to surgery or radiation. The risk is presumed to relate to its cytotoxicity.... 
BREAST-CANCER | INTRACELLULAR CA2 | RISK-FACTORS | PLASMA | PHARMACOKINETICS | CALCIUM-RELEASE | HPLC METHOD | CANCER-RELATED LYMPHEDEMA | PHARMACOLOGY & PHARMACY | SARCOPLASMIC-RETICULUM | ARM LYMPHEDEMA | Index Medicus
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2014, Volume 156, Issue 5, pp. 1261 - 1268
Journal Article
Journal Article